SPDR S&P PHARMACEUTICALS ETF (XPH) Institutional Ownership Changes & 13F Activity
SPDR S&P PHARMACEUTICALS ETF (XPH). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Morgan Stanley, Envestnet Asset Management Inc, Quadrature Capital Ltd, Wells Fargo & Company/Mn, and Teucrium Investment Advisors, Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Envestnet Asset Management Inc | Buy | +166,879 | +75.2% | 388,701 | $25.27M | Q3 2026 | Nov 16, 2026 |
| Wells Fargo & Company/Mn | Buy | +45,285 | +11.7% | 432,653 | $28.12M | Q3 2026 | Nov 16, 2026 |
| Teucrium Investment Advisors, Llc | Buy | +44,177 | — | 44,177 | $2.87M | Q3 2026 | Nov 16, 2026 |
| Bank Of America Corp | Buy | +38,041 | +3.7% | 1,053,935 | $68.51M | Q3 2026 | Nov 16, 2026 |
| Royal Bank Of Canada | Buy | +35,320 | +161.2% | 57,237 | $3.72M | Q3 2026 | Nov 16, 2026 |
| Gts Securities Llc | Sell | -17,758 | -66.1% | 9,127 | $593.25K | Q3 2026 | Nov 16, 2026 |
| Garden State Investment Advisory Services Llc | Buy | +14,310 | — | 14,310 | $930.15K | Q3 2026 | Nov 16, 2026 |
| Goldman Sachs Group Inc | Buy | +12,347 | +47.1% | 38,578 | $2.51M | Q3 2026 | Nov 16, 2026 |
| Clark Capital Management Group, Inc. | Sell | -10,186 | -30.9% | 22,743 | $1.48M | Q3 2026 | Nov 16, 2026 |
| Susquehanna International Group, Llp | Buy | +8,805 | +27.5% | 40,817 | $2.65M | Q3 2026 | Nov 16, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +6,253 | +54.8% | 17,669 | $1.15M | Q3 2026 | Nov 16, 2026 |
| Millennium Management Llc | Buy | +3,727 | — | 3,727 | $242.25K | Q3 2026 | Nov 16, 2026 |
| &Partners | Buy | +3,598 | — | 3,598 | $233.90K | Q3 2026 | Nov 16, 2026 |
| Beacon Pointe Advisors, Llc | Buy | +1,524 | +26.6% | 7,255 | $471.60K | Q3 2026 | Nov 16, 2026 |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | Buy | +640 | — | 640 | $41.60K | Q3 2026 | Nov 16, 2026 |
| Ameriflex Group, Inc. | Buy | +400 | — | 400 | $26.00K | Q3 2026 | Nov 16, 2026 |
| Strategic Financial Concepts, Llc | Buy | +129 | — | 129 | $8.38K | Q3 2026 | Nov 16, 2026 |
| Vista Investment Management | Sell | -102 | -2.6% | 3,884 | $252.46K | Q3 2026 | Nov 16, 2026 |
| Corient Private Wealth Llc | Buy | +4 | +0.1% | 3,405 | $221.32K | Q3 2026 | Nov 16, 2026 |
| Cohen & Steers, Inc. | Buy | +2 | — | 2 | $0.00 | Q3 2026 | Nov 16, 2026 |
| Morgan Stanley | Buy | +216,946 | +69.0% | 531,172 | $34.53M | Q3 2026 | Nov 13, 2026 |
| Quadrature Capital Ltd | Buy | +61,576 | — | 61,576 | $4.00M | Q3 2026 | Nov 13, 2026 |
| Kingsview Wealth Management, Llc | Sell | -29,688 | -9.4% | 285,206 | $18.54M | Q3 2026 | Nov 13, 2026 |
| Qube Research & Technologies Ltd | Buy | +17,742 | +7713.9% | 17,972 | $1.17M | Q3 2026 | Nov 13, 2026 |
| Cetera Investment Advisers | Buy | +14,494 | +29.6% | 63,498 | $4.13M | Q3 2026 | Nov 13, 2026 |
| Rockefeller Capital Management L.P. | Buy | +9,029 | +47.9% | 27,892 | $1.81M | Q3 2026 | Nov 13, 2026 |
| V2 Financial Group Llc | Buy | +3,200 | — | 3,200 | $208.00K | Q3 2026 | Nov 13, 2026 |
| Northwestern Mutual Wealth Management Co | Buy | +2,144 | — | 2,144 | $139.36K | Q3 2026 | Nov 13, 2026 |
| Mml Investors Services, Llc | Sell | -2,059 | -10.3% | 17,913 | $1.16M | Q3 2026 | Nov 13, 2026 |
| Baird Financial Group, Inc. | Sell | -1,938 | -6.8% | 26,530 | $1.72M | Q3 2026 | Nov 13, 2026 |
Frequently asked questions about XPH activity
Which institutional owners are buying XPH?
Institutional owners buying XPH include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in XPH activity?
"Buy" means an investor increased their reported position in XPH compared to the prior reporting period. This reflects growing exposure to SPDR S&P PHARMACEUTICALS ETF (XPH) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in XPH increasing?
Institutional interest in XPH can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.